Johnson & Johnson vaccine to resume after pause over rare blood clot cases in some women under 50
The CDC is lifting its pause on Johnson & Johnson vaccines after a nearly 10-day pause due to concerns about blood clots. New vaccines will come with an FDA warning. Johns Hopkins International Vaccine Access Center executive director Dr. Bill Moss joins CBSN to discuss the vaccine.